Patents | Published:

Will inter partes review speed US generic drug entry?

Nature Biotechnology volume 35, pages 11391141 (2017) | Download Citation

A new extra-judicial pathway for challenging pharmaceutical patents has intensified patent challenges and helped to clear the way for earlier generic entry.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Leahy-Smith America Invents Act, Pub. L. No. 112–29, 125 Stat. 284 (2011).

  2. 2.

    21 USC § 355(j)(2)(vii)(IV) (2017).

  3. 3.

    et al. J. Med. Econ. 19, 836–844 (2016).

  4. 4.

    & 2015 Report of the Economic Survey. AIPLA (June 2015).

  5. 5.

    et al. Finnegan (7 March, 2014).

  6. 6.

    37 CFR § 42.100(b) (2016).

  7. 7.

    Phillips v. AWH Corp., 415 F.3d 1303, 1314 (Fed. Cir. 2005) (en banc).

  8. 8.

    George Washington Law Rev. 83, 28–46 (2015).

  9. 9.

    Unified Patents.

  10. 10.

    Corp Counsel (9 March, 2016).

  11. 11.

    Judgment on request for adverse judgment, Lupin Limited v. Vertex Pharm. Inc., IPR2015–00405, Paper No. 28 (PTAB 3 November, 2015).

  12. 12.

    Final written decision, Lupin Limited v. Vertex Pharm. Inc., No. IPR2016–00558, Paper No. 39 (PTAB 2 August, 2016).

  13. 13.

    Allergan, Inc. v. Teva Pharm. USA, Inc., No. 2:15-cv-1455-WCB, 2017 WL 4619790 (E.D. Tex. 16 October, 2017) (Bryson, J.).

  14. 14.

    Lewis v. Clarke, 137 S. Ct. 1285 (2017).

  15. 15.

    S. 1948, 115th Cong. 1st Sess. (5 October, 2017).

  16. 16.

    Oil States Energy Servs., LLC v. Greene's Energy Grp., LLC, 137 S. Ct. 2239 (2017).

Download references

Author information

Affiliations

  1. Jonathan J. Darrow, Reed F. Beall and Aaron S. Kesselheim are at the Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

    • Jonathan J Darrow
    • , Reed F Beall
    •  & Aaron S Kesselheim

Authors

  1. Search for Jonathan J Darrow in:

  2. Search for Reed F Beall in:

  3. Search for Aaron S Kesselheim in:

Competing interests

A.S.K. work is supported by the Laura and John Arnold Foundation, with additional support from the Harvard Program in Therapeutic Science and the Engelberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Corresponding author

Correspondence to Jonathan J Darrow.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nbt.4036

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing